{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:55:02Z","timestamp":1784357702628,"version":"3.55.0"},"publisher-location":"Cham","reference-count":96,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031598142","type":"print"},{"value":"9783031598159","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-59815-9_26","type":"book-chapter","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:01:55Z","timestamp":1723154515000},"page":"385-397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Autoinflammatory Contributors to Cytokine Storm"],"prefix":"10.1007","author":[{"given":"Scott W.","family":"Canna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"26_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric, S. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2\u20138. https:\/\/doi.org\/10.1097\/01.PCC.0000149131.72248.E6.","journal-title":"Pediatr Crit Care Med"},{"key":"26_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0092-8674(00)80721-7","volume":"97","author":"MF McDermott","year":"1999","unstructured":"McDermott MF, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell. 1999;97:133\u201344. https:\/\/doi.org\/10.1016\/s0092-8674(00)80721-7.","journal-title":"Cell"},{"key":"26_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJM199206043262301","volume":"326","author":"E Pras","year":"1992","unstructured":"Pras E, et al. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med. 1992;326:1509\u201313. https:\/\/doi.org\/10.1056\/NEJM199206043262301.","journal-title":"N Engl J Med"},{"key":"26_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301\u20135. https:\/\/doi.org\/10.1038\/ng756.","journal-title":"Nat Genet"},{"key":"26_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/341357","volume":"71","author":"J Feldmann","year":"2002","unstructured":"Feldmann J, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71:198\u2013203. https:\/\/doi.org\/10.1086\/341357.","journal-title":"Am J Hum Genet"},{"key":"26_CR6","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1002\/art.10688","volume":"46","author":"I Aksentijevich","year":"2002","unstructured":"Aksentijevich I, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340\u20138. https:\/\/doi.org\/10.1002\/art.10688.","journal-title":"Arthritis Rheum"},{"key":"26_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","volume":"33","author":"AA de Jesus","year":"2015","unstructured":"de Jesus AA, Canna SW, Liu Y, Goldbach-Mansky R. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling. Annu Rev Immunol. 2015;33:823\u201374. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112227.","journal-title":"Annu Rev Immunol"},{"key":"26_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1074-7613(04)00046-9","volume":"20","author":"L Agostini","year":"2004","unstructured":"Agostini L, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319\u201325. https:\/\/doi.org\/10.1016\/s1074-7613(04)00046-9.","journal-title":"Immunity"},{"key":"26_CR9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","volume":"593","author":"S Xia","year":"2021","unstructured":"Xia S, et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021;593:607\u201311. https:\/\/doi.org\/10.1038\/s41586-021-03478-3.","journal-title":"Nature"},{"key":"26_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16:407\u201320. https:\/\/doi.org\/10.1038\/nri.2016.58.","journal-title":"Nat Rev Immunol"},{"key":"26_CR11","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ni.3457","volume":"17","author":"YH Park","year":"2016","unstructured":"Park YH, Wood G, Kastner DL, Chae JJ. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat Immunol. 2016;17:914\u201321. https:\/\/doi.org\/10.1038\/ni.3457.","journal-title":"Nat Immunol"},{"key":"26_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140\u20136. https:\/\/doi.org\/10.1038\/ng.3089.","journal-title":"Nat Genet"},{"key":"26_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ng.3066","volume":"46","author":"N Romberg","year":"2014","unstructured":"Romberg N, et al. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet. 2014;46:1135\u20139. https:\/\/doi.org\/10.1038\/ng.3066.","journal-title":"Nat Genet"},{"key":"26_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355:581\u201392. https:\/\/doi.org\/10.1056\/NEJMoa055137.","journal-title":"N Engl J Med"},{"key":"26_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/art.20033","volume":"50","author":"PN Hawkins","year":"2004","unstructured":"Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum. 2004;50:607\u201312. https:\/\/doi.org\/10.1002\/art.20033.","journal-title":"Arthritis Rheum"},{"key":"26_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/BOR.0000000000000422","volume":"29","author":"P Tsoukas","year":"2017","unstructured":"Tsoukas P, Canna SW. No shortcuts: new findings reinforce why nuance is the rule in genetic autoinflammatory syndromes. Curr Opin Rheumatol. 2017;29:506\u201315. https:\/\/doi.org\/10.1097\/BOR.0000000000000422.","journal-title":"Curr Opin Rheumatol"},{"key":"26_CR17","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","volume":"18","author":"K Manthiram","year":"2017","unstructured":"Manthiram K, Zhou Q, Aksentijevich I, Kastner DL. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat Immunol. 2017;18:832\u201342. https:\/\/doi.org\/10.1038\/ni.3777.","journal-title":"Nat Immunol"},{"key":"26_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-pathmechdis-030121-041528","volume":"17","author":"JE Rood","year":"2022","unstructured":"Rood JE, Behrens EM. Inherited Autoinflammatory Syndromes. Annu Rev Pathol. 2022;17:227\u201349. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-030121-041528.","journal-title":"Annu Rev Pathol"},{"key":"26_CR19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/521373","volume":"81","author":"G Rice","year":"2007","unstructured":"Rice G, et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet. 2007;81:713\u201325. https:\/\/doi.org\/10.1086\/521373.","journal-title":"Am J Hum Genet"},{"key":"26_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210565","volume":"75","author":"V Tungler","year":"2016","unstructured":"Tungler V, et al. Response to: \u2018JAK inhibition in STING-associated interferonopathy\u2019 by Crow et al. Ann Rheum Dis. 2016;75:e76. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210565.","journal-title":"Ann Rheum Dis"},{"key":"26_CR21","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","volume":"360","author":"I Aksentijevich","year":"2009","unstructured":"Aksentijevich I, et al. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. N Engl J Med. 2009;360:2426\u201337. https:\/\/doi.org\/10.1056\/NEJMoa0807865.","journal-title":"N Engl J Med"},{"key":"26_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10875-017-0399-1","volume":"37","author":"LO Mendonca","year":"2017","unstructured":"Mendonca LO, et al. Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN. J Clin Immunol. 2017;37:445\u201351. https:\/\/doi.org\/10.1007\/s10875-017-0399-1.","journal-title":"J Clin Immunol"},{"key":"26_CR23","first-page":"2070","volume":"34","author":"B Koc","year":"2007","unstructured":"Koc B, et al. The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. J Rheumatol. 2007;34:2070\u20135.","journal-title":"J Rheumatol"},{"key":"26_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/eji.200940225","volume":"40","author":"IG Rodrigue-Gervais","year":"2010","unstructured":"Rodrigue-Gervais IG, Saleh M. Genetics of inflammasome-associated disorders: a lesson in the guiding principals of inflammasome function. Eur J Immunol. 2010;40:643\u20138. https:\/\/doi.org\/10.1002\/eji.200940225.","journal-title":"Eur J Immunol"},{"key":"26_CR25","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","volume":"213","author":"GS Schulert","year":"2016","unstructured":"Schulert GS, et al. Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza. J Infect Dis. 2016;213:1180\u20138. https:\/\/doi.org\/10.1093\/infdis\/jiv550.","journal-title":"J Infect Dis"},{"key":"26_CR26","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10875-021-01183-4","volume":"42","author":"KF Kernan","year":"2022","unstructured":"Kernan KF, et al. Prevalence of Pathogenic and Potentially Pathogenic Inborn Error of Immunity Associated Variants in Children with Severe Sepsis. J Clin Immunol. 2022;42:350\u201364. https:\/\/doi.org\/10.1007\/s10875-021-01183-4.","journal-title":"J Clin Immunol"},{"key":"26_CR27","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.1073\/pnas.1520779112","volume":"112","author":"MJ Ombrello","year":"2015","unstructured":"Ombrello MJ, et al. HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci USA. 2015;112:15970\u20135. https:\/\/doi.org\/10.1073\/pnas.1520779112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"26_CR28","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1112802.","journal-title":"N Engl J Med"},{"key":"26_CR29","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2396\u2013406. https:\/\/doi.org\/10.1056\/NEJMoa1205099.","journal-title":"N Engl J Med"},{"key":"26_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","volume":"76","author":"MJ Ombrello","year":"2017","unstructured":"Ombrello MJ, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017;76:906\u201313. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210324.","journal-title":"Ann Rheum Dis"},{"key":"26_CR31","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131:1442\u201355. https:\/\/doi.org\/10.1182\/blood-2017-12-820852.","journal-title":"Blood"},{"key":"26_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.42099","volume":"74","author":"G Chen","year":"2022","unstructured":"Chen G, et al. Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers. Arthritis Rheumatol. 2022;74:1271. https:\/\/doi.org\/10.1002\/art.42099.","journal-title":"Arthritis Rheumatol"},{"key":"26_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/cei.13543","volume":"203","author":"JM Krei","year":"2021","unstructured":"Krei JM, Moller HJ, Larsen JB. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome - a systematic review. Clin Exp Immunol. 2021;203:174\u201382. https:\/\/doi.org\/10.1111\/cei.13543.","journal-title":"Clin Exp Immunol"},{"key":"26_CR34","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","volume":"49","author":"M Shimizu","year":"2010","unstructured":"Shimizu M, et al. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford). 2010;49:1645\u201353. https:\/\/doi.org\/10.1093\/rheumatology\/keq133.","journal-title":"Rheumatology (Oxford)"},{"key":"26_CR35","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","volume":"77","author":"C Gabay","year":"2018","unstructured":"Gabay C, et al. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still\u2019s disease. Ann Rheum Dis. 2018;77:840\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212608.","journal-title":"Ann Rheum Dis"},{"key":"26_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10875-022-01353-y","volume":"43","author":"JE Rood","year":"2022","unstructured":"Rood JE, et al. Improvement of refractory systemic juvenile idiopathic arthritis-associated lung disease with single-agent blockade of IL-1beta and IL-18. J Clin Immunol. 2022;43:101. https:\/\/doi.org\/10.1007\/s10875-022-01353-y.","journal-title":"J Clin Immunol"},{"key":"26_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/ACI.0000000000000396","volume":"17","author":"N Romberg","year":"2017","unstructured":"Romberg N, Vogel TP, Canna SW. NLRC4 inflammasomopathies. Curr Opin Allergy Clin Immunol. 2017;17:398\u2013404. https:\/\/doi.org\/10.1097\/ACI.0000000000000396.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"26_CR38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1093526616686890","volume":"20","author":"J Liang","year":"2017","unstructured":"Liang J, et al. Novel NLRC4 mutation causes a syndrome of perinatal autoinflammation with hemophagocytic lymphohistiocytosis, hepatosplenomegaly, fetal thrombotic vasculopathy, and congenital anemia and ascites. Pediatr Dev Pathol. 2017;20:498\u2013505. https:\/\/doi.org\/10.1177\/1093526616686890.","journal-title":"Pediatr Dev Pathol"},{"key":"26_CR39","doi-asserted-by":"publisher","first-page":"1956\u20131967 e1956","DOI":"10.1016\/j.jaci.2018.04.033","volume":"142","author":"F Moghaddas","year":"2018","unstructured":"Moghaddas F, et al. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface. J Allergy Clin Immunol. 2018;142:1956\u20131967 e1956. https:\/\/doi.org\/10.1016\/j.jaci.2018.04.033.","journal-title":"J Allergy Clin Immunol"},{"key":"26_CR40","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","volume":"139","author":"SW Canna","year":"2017","unstructured":"Canna SW, et al. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. J Allergy Clin Immunol. 2017;139:1698\u2013701. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.022.","journal-title":"J Allergy Clin Immunol"},{"key":"26_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/bjd.14757","volume":"176","author":"CM Volker-Touw","year":"2017","unstructured":"Volker-Touw CM, et al. Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype. Br J Dermatol. 2017;176:244\u20138. https:\/\/doi.org\/10.1111\/bjd.14757.","journal-title":"Br J Dermatol"},{"key":"26_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108328","volume":"211","author":"CT Chear","year":"2020","unstructured":"Chear CT, et al. A novel de novo NLRC4 mutation reinforces the likely pathogenicity of specific LRR domain mutation. Clin Immunol. 2020;211:108328. https:\/\/doi.org\/10.1016\/j.clim.2019.108328.","journal-title":"Clin Immunol"},{"key":"26_CR43","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/kew300","volume":"55","author":"C Girard","year":"2016","unstructured":"Girard C, et al. Elevated serum levels of free interleukin-18 in adult-onset Still\u2019s disease. Rheumatology (Oxford). 2016;55:2237\u201347. https:\/\/doi.org\/10.1093\/rheumatology\/kew300.","journal-title":"Rheumatology (Oxford)"},{"key":"26_CR44","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1002\/pbc.25206","volume":"62","author":"C Bracaglia","year":"2015","unstructured":"Bracaglia C, et al. Abstract: Anti Interferon-Gamma (IFN gamma) monoclonal antibody treatment in a child with nlrc4-related disease and severe hemophagocytic lymphohistiocytosis (HLH). Pediatr Blood Cancer. 2015;62:S123.","journal-title":"Pediatr Blood Cancer"},{"key":"26_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76:166\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2015-209020.","journal-title":"Ann Rheum Dis"},{"key":"26_CR46","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","volume":"131","author":"C Girard-Guyonvarc\u2019h","year":"2018","unstructured":"Girard-Guyonvarc\u2019h C, et al. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice. Blood. 2018;131:1430\u201341. https:\/\/doi.org\/10.1182\/blood-2017-06-789552.","journal-title":"Blood"},{"key":"26_CR47","doi-asserted-by":"crossref","unstructured":"Wang J, Ye Q, Zheng W, Yu X, Luo F, Fang R, et al. Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease. Ann Rheum Dis. 2022;81(8):1173\u20138.","DOI":"10.1136\/annrheumdis-2021-221708"},{"key":"26_CR48","doi-asserted-by":"crossref","unstructured":"De Langhe E, Van Loo S, Malengier-Devlies B, Metzemaekers M, Staels F, Vandenhaute J, et al. TET2-Driver and NLRC4-Passenger Variants in Adult-Onset Autoinflammation. The New England journal of medicine. 2023;388(17):1626\u20139.","DOI":"10.1056\/NEJMc2212928"},{"key":"26_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud S, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444:110\u20134. https:\/\/doi.org\/10.1038\/nature05257.","journal-title":"Nature"},{"key":"26_CR50","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","volume":"116","author":"RA Marsh","year":"2010","unstructured":"Marsh RA, et al. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood. 2010;116:1079\u201382. https:\/\/doi.org\/10.1182\/blood-2010-01-256099.","journal-title":"Blood"},{"key":"26_CR51","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.celrep.2017.06.073","volume":"20","author":"KE Lawlor","year":"2017","unstructured":"Lawlor KE, et al. XIAP loss triggers RIPK3- and caspase-8-driven IL-1beta activation and cell death as a consequence of TLR-MyD88-induced cIAP1-TRAF2 degradation. Cell Rep. 2017;20:668\u201382. https:\/\/doi.org\/10.1016\/j.celrep.2017.06.073.","journal-title":"Cell Rep"},{"key":"26_CR52","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ceb.2012.11.004","volume":"24","author":"NS Kenneth","year":"2012","unstructured":"Kenneth NS, Duckett CS. IAP proteins: regulators of cell migration and development. Curr Opin Cell Biol. 2012;24:871\u20135. https:\/\/doi.org\/10.1016\/j.ceb.2012.11.004.","journal-title":"Curr Opin Cell Biol"},{"key":"26_CR53","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","volume":"7","author":"M Yabal","year":"2014","unstructured":"Yabal M, et al. XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation. Cell Rep. 2014;7:1796\u2013808. https:\/\/doi.org\/10.1016\/j.celrep.2014.05.008.","journal-title":"Cell Rep"},{"key":"26_CR54","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1182\/blood.2021014335","volume":"140","author":"SCC Chiang","year":"2022","unstructured":"Chiang SCC, et al. Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Blood. 2022;140:706\u201315. https:\/\/doi.org\/10.1182\/blood.2021014335.","journal-title":"Blood"},{"key":"26_CR55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","volume":"65","author":"T Wada","year":"2014","unstructured":"Wada T, et al. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine. 2014;65:74\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2013.09.007.","journal-title":"Cytokine"},{"key":"26_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.clim.2013.07.004","volume":"149","author":"C Speckmann","year":"2013","unstructured":"Speckmann C, et al. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis. Clin Immunol. 2013;149:133\u201341. https:\/\/doi.org\/10.1016\/j.clim.2013.07.004.","journal-title":"Clin Immunol"},{"key":"26_CR57","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1084\/jem.20141091","volume":"211","author":"A Kitamura","year":"2014","unstructured":"Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K. An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med. 2014;211:2385\u201396. https:\/\/doi.org\/10.1084\/jem.20141091.","journal-title":"J Exp Med"},{"key":"26_CR58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/art.39960","volume":"69","author":"Y Kawasaki","year":"2017","unstructured":"Kawasaki Y, et al. Identification of a high-frequency somatic NLRC4 mutation as a cause of autoinflammation by pluripotent cell-based phenotype dissection. Arthritis Rheumatol. 2017;69:447\u201359. https:\/\/doi.org\/10.1002\/art.39960.","journal-title":"Arthritis Rheumatol"},{"key":"26_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10875-021-01175-4","volume":"42","author":"A Steiner","year":"2021","unstructured":"Steiner A, et al. Recessive NLRC4-autoinflammatory disease reveals an ulcerative colitis locus. J Clin Immunol. 2021;42:325. https:\/\/doi.org\/10.1007\/s10875-021-01175-4.","journal-title":"J Clin Immunol"},{"key":"26_CR60","doi-asserted-by":"publisher","first-page":"1122-1125 e1126","DOI":"10.1016\/j.jaci.2019.06.017","volume":"144","author":"Y Gernez","year":"2019","unstructured":"Gernez Y, et al. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1beta inhibition. J Allergy Clin Immunol. 2019;144:1122-1125 e1126. https:\/\/doi.org\/10.1016\/j.jaci.2019.06.017.","journal-title":"J Allergy Clin Immunol"},{"key":"26_CR61","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1084\/jem.20190147","volume":"216","author":"MT Lam","year":"2019","unstructured":"Lam MT, et al. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function. J Exp Med. 2019;216:2778\u201399. https:\/\/doi.org\/10.1084\/jem.20190147.","journal-title":"J Exp Med"},{"key":"26_CR62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2022.01.024","volume":"150","author":"S Coppola","year":"2022","unstructured":"Coppola S, et al. Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders. J Allergy Clin Immunol. 2022;150:223. https:\/\/doi.org\/10.1016\/j.jaci.2022.01.024.","journal-title":"J Allergy Clin Immunol"},{"key":"26_CR63","doi-asserted-by":"publisher","unstructured":"Nishitani-Isa M, et al. Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation. J Exp Med. 2022;219 https:\/\/doi.org\/10.1084\/jem.20211889.","DOI":"10.1084\/jem.20211889"},{"key":"26_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41586-020-2422-6","volume":"583","author":"T Zhou","year":"2020","unstructured":"Zhou T, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609\u201314. https:\/\/doi.org\/10.1038\/s41586-020-2422-6.","journal-title":"Nature"},{"key":"26_CR65","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.20190669","volume":"216","author":"S Belkaya","year":"2019","unstructured":"Belkaya S, et al. Inherited IL-18BP deficiency in human fulminant viral hepatitis. J Exp Med. 2019;216:1777\u201390. https:\/\/doi.org\/10.1084\/jem.20190669.","journal-title":"J Exp Med"},{"key":"26_CR66","doi-asserted-by":"crossref","unstructured":"Wolf C, Fischer H, Kuhl JS, Koss S, Abou Jamra R, Starke S, et al. Hemophagocytic lymphohistiocytosis-like hyperinflammation due to a de novo mutation in DPP9. The Journal of allergy and clinical immunology. 2023;152(5):1336\u201344 e5.","DOI":"10.1016\/j.jaci.2023.07.013"},{"key":"26_CR67","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/art.24750","volume":"60","author":"W de Jager","year":"2009","unstructured":"de Jager W, et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2009;60:2782\u201393. https:\/\/doi.org\/10.1002\/art.24750.","journal-title":"Arthritis Rheum"},{"key":"26_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/art.39933","volume":"69","author":"K Put","year":"2017","unstructured":"Put K, et al. Inflammatory gene expression profile and defective interferon-gamma and Granzyme K in natural killer cells from systemic juvenile idiopathic arthritis Patients. Arthritis Rheumatol. 2017;69:213\u201324. https:\/\/doi.org\/10.1002\/art.39933.","journal-title":"Arthritis Rheumatol"},{"key":"26_CR69","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1182\/blood.2019003846","volume":"136","author":"P Tsoukas","year":"2020","unstructured":"Tsoukas P, et al. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation. Blood. 2020;136:2162\u201374. https:\/\/doi.org\/10.1182\/blood.2019003846.","journal-title":"Blood"},{"key":"26_CR70","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.immuni.2015.01.011","volume":"42","author":"M Munoz","year":"2015","unstructured":"Munoz M, et al. Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection. Immunity. 2015;42:321\u201331. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.011.","journal-title":"Immunity"},{"key":"26_CR71","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","volume":"163","author":"R Nowarski","year":"2015","unstructured":"Nowarski R, et al. Epithelial IL-18 equilibrium controls barrier function in colitis. Cell. 2015;163:1444\u201356. https:\/\/doi.org\/10.1016\/j.cell.2015.10.072.","journal-title":"Cell"},{"key":"26_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2017.03.016","volume":"46","author":"I Rauch","year":"2017","unstructured":"Rauch I, et al. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8. Immunity. 2017;46:649\u201359. https:\/\/doi.org\/10.1016\/j.immuni.2017.03.016.","journal-title":"Immunity"},{"key":"26_CR73","doi-asserted-by":"publisher","first-page":"444-456 e414","DOI":"10.1016\/j.cell.2016.08.076","volume":"167","author":"A Chudnovskiy","year":"2016","unstructured":"Chudnovskiy A, et al. Host-protozoan interactions protect from mucosal infections through activation of the inflammasome. Cell. 2016;167:444-456 e414. https:\/\/doi.org\/10.1016\/j.cell.2016.08.076.","journal-title":"Cell"},{"key":"26_CR74","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/art.41976","volume":"74","author":"DL Stone","year":"2022","unstructured":"Stone DL, et al. Excess serum interleukin-18 distinguishes patients with pathogenic mutations in PSTPIP1. Arthritis Rheumatol. 2022;74:353\u20137. https:\/\/doi.org\/10.1002\/art.41976.","journal-title":"Arthritis Rheumatol"},{"key":"26_CR75","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1182\/blood-2010-12-324533","volume":"118","author":"JE Lykens","year":"2011","unstructured":"Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB. Perforin is a critical physiologic regulator of T-cell activation. Blood. 2011;118:618\u201326. https:\/\/doi.org\/10.1182\/blood-2010-12-324533; blood-2010-12-324533 [pii]","journal-title":"Blood"},{"key":"26_CR76","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1182\/blood-2015-07-659813","volume":"127","author":"JE Rood","year":"2016","unstructured":"Rood JE, et al. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice. Blood. 2016;127:426\u201335. https:\/\/doi.org\/10.1182\/blood-2015-07-659813.","journal-title":"Blood"},{"key":"26_CR77","doi-asserted-by":"publisher","first-page":"LBA-3","DOI":"10.1182\/blood.V126.23.LBA-3.LBA-3","volume":"126","author":"MB Jordan","year":"2015","unstructured":"Jordan MB, et al. Abstract: a novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFN\u03b3) monoclonal antibody (mAb), NI-0501: first results from a pilot phase 2 study in children with primary HLH. Blood. 2015;126:LBA-3.","journal-title":"Blood"},{"key":"26_CR78","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1182\/blood-2011-01-329607","volume":"117","author":"P Krebs","year":"2011","unstructured":"Krebs P, Crozat K, Popkin D, Oldstone MB, Beutler B. Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice. Blood. 2011;117:6582\u20138. https:\/\/doi.org\/10.1182\/blood-2011-01-329607.","journal-title":"Blood"},{"key":"26_CR79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20140964","volume":"212","author":"MR Jenkins","year":"2015","unstructured":"Jenkins MR, et al. Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time. J Exp Med. 2015;212:307\u201317. https:\/\/doi.org\/10.1084\/jem.20140964.","journal-title":"J Exp Med"},{"key":"26_CR80","doi-asserted-by":"publisher","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","volume":"121","author":"CE Terrell","year":"2013","unstructured":"Terrell CE, Jordan MB. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells. Blood. 2013;121:5184\u201391. https:\/\/doi.org\/10.1182\/blood-2013-04-495309.","journal-title":"Blood"},{"key":"26_CR81","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","volume":"125","author":"FE Sepulveda","year":"2015","unstructured":"Sepulveda FE, et al. A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood. 2015;125:1427\u201334. https:\/\/doi.org\/10.1182\/blood-2014-09-602946.","journal-title":"Blood"},{"key":"26_CR82","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1084\/jem.20102538","volume":"208","author":"EE Zoller","year":"2011","unstructured":"Zoller EE, et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med. 2011;208:1203\u201314. https:\/\/doi.org\/10.1084\/jem.20102538.","journal-title":"J Exp Med"},{"key":"26_CR83","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.88181","volume":"1","author":"M Wunderlich","year":"2016","unstructured":"Wunderlich M, et al. A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment. JCI Insight. 2016;1:e88181. https:\/\/doi.org\/10.1172\/jci.insight.88181.","journal-title":"JCI Insight"},{"key":"26_CR84","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1093\/rheumatology\/keaa242","volume":"59","author":"SE Jorgensen","year":"2020","unstructured":"Jorgensen SE, et al. Systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome due to a CASP1 variant causing inflammasome hyperactivation. Rheumatology (Oxford). 2020;59:3099\u2013105. https:\/\/doi.org\/10.1093\/rheumatology\/keaa242.","journal-title":"Rheumatology (Oxford)"},{"key":"26_CR85","doi-asserted-by":"publisher","first-page":"1441-1445 e1417","DOI":"10.1016\/j.jaci.2019.07.038","volume":"144","author":"B Volkmer","year":"2019","unstructured":"Volkmer B, et al. Recurrent inflammatory disease caused by a heterozygous mutation in CD48. J Allergy Clin Immunol. 2019;144:1441-1445 e1417. https:\/\/doi.org\/10.1016\/j.jaci.2019.07.038.","journal-title":"J Allergy Clin Immunol"},{"key":"26_CR86","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","volume":"50","author":"T Gayden","year":"2018","unstructured":"Gayden T, et al. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome. Nat Genet. 2018;50:1650\u20137. https:\/\/doi.org\/10.1038\/s41588-018-0251-4.","journal-title":"Nat Genet"},{"key":"26_CR87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1182\/blood.2019003811","volume":"135","author":"G Sonigo","year":"2020","unstructured":"Sonigo G, et al. HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma. Blood. 2020;135:1058\u201361. https:\/\/doi.org\/10.1182\/blood.2019003811.","journal-title":"Blood"},{"key":"26_CR88","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.aay5663","volume":"369","author":"SA Cook","year":"2020","unstructured":"Cook SA, et al. HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease. Science. 2020;369:202\u20137. https:\/\/doi.org\/10.1126\/science.aay5663.","journal-title":"Science"},{"key":"26_CR89","doi-asserted-by":"publisher","unstructured":"Castro CN, et al. NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation. J Exp Med. 2020;217 https:\/\/doi.org\/10.1084\/jem.20192275.","DOI":"10.1084\/jem.20192275"},{"key":"26_CR90","doi-asserted-by":"publisher","unstructured":"Salzer E, et al. The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity. Sci Immunol. 2020;5 https:\/\/doi.org\/10.1126\/sciimmunol.abc3979.","DOI":"10.1126\/sciimmunol.abc3979"},{"key":"26_CR91","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajmg.c.30287","volume":"157C","author":"G Sebastio","year":"2011","unstructured":"Sebastio G, Sperandeo MP, Andria G. Lysinuric protein intolerance: reviewing concepts on a multisystem disease. Am J Med Genet C Semin Med Genet. 2011;157C:54\u201362. https:\/\/doi.org\/10.1002\/ajmg.c.30287.","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"26_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13023-016-0550-8","volume":"12","author":"W Mauhin","year":"2017","unstructured":"Mauhin W, et al. Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood. Orphanet J Rare Dis. 2017;12:3.","journal-title":"Orphanet J Rare Dis"},{"key":"26_CR93","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3389\/fimmu.2018.00508","volume":"9","author":"BM Rotoli","year":"2018","unstructured":"Rotoli BM, et al. Downregulation of SLC7A7 triggers an inflammatory phenotype in human macrophages and airway epithelial cells. Front Immunol. 2018;9:508.","journal-title":"Front Immunol"},{"key":"26_CR94","doi-asserted-by":"publisher","unstructured":"Duncan CJA, et al. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Sci Immunol. 2019;4 https:\/\/doi.org\/10.1126\/sciimmunol.aav7501.","DOI":"10.1126\/sciimmunol.aav7501"},{"key":"26_CR95","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44:275\u201381. https:\/\/doi.org\/10.1097\/CCM.0000000000001402.","journal-title":"Crit Care Med"},{"key":"26_CR96","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/art.40071","volume":"69","author":"EM Behrens","year":"2017","unstructured":"Behrens EM, Koretzky GA. Cytokine storm syndrome: looking toward the precision medicine era. Arthritis Rheum. 2017;69:1135\u201343.","journal-title":"Arthritis Rheum"}],"container-title":["Advances in Experimental Medicine and Biology","Cytokine Storm Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-59815-9_26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T22:06:05Z","timestamp":1723154765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-59815-9_26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031598142","9783031598159"],"references-count":96,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-59815-9_26","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"9 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}